Specialized teaching and hands-on training experiences are crucial for the career development of neuroscience researchers. The IBRO Neuroscience Training Grants are designed to support these essential opportunities, covering costs directly associated with the attendance of a neuroscience training course, such as course fees, travel and accommodation.
By eliminating financial barriers, IBRO aims to ensure that early-career neuroscientists, particularly those from under-resourced regions, can access high quality training. This initiative is part of IBRO’s broader commitment to promoting diversity, equity, and inclusion in neuroscience research and education.
Benefits
Eligible costs
Training course registration fees
Travel related to the training course
Local expenses
Ineligible costs
Costs related to a conference/meeting attendance
Costs related to an exchange stay at another laboratory
Maximum grant amounts
The maximum grant amount an applicant can request varies based on their region of residence and is determined by the corresponding IBRO Regional Committee. Please note the specific amounts below:
Africa: 5,000 USDAsia-Pacific: 3,000 USDLatin America: 6,000 USDPan-Europe: 4,500 USDUS/Canada: 4,000 USD
Requirements
Applications are open to PhD students and early-career postdoctoral fellows who are within 5 years of starting their first postdoctoral fellowship.
These grants are intended for those planning to attend a neuroscience training course taking place between 1 July and 31 December 2025.
Applications from students wishing to attend an IBRO-Supported School will not be taken into consideration for this program. Please apply directly to the school of interest via the dedicated application page, as indicated in the IBRO Training page
Method of Application
Click Here to Apply
Create an applicant account here.
Refer to the Frequently Asked Questions (FAQs) for any inquiries.
For technical issues with the site, submit a customer support request form.
For More Information,
Visit the Official Webpage
Application Deadline: May 31, 2025.
